U.S. records 71 new measles cases in week as outbreak spreads
(Adds information from the news release, background on global
April 22 (Reuters) - The United States recorded 71 new
measles cases last week, a 13 percent increase as the country
faces its second-worst outbreak of the disease in almost two
decades, federal health officials said on Monday.
The U.S. Centers for Disease Control and Prevention said it
had recorded 626 cases of the highly contagious and sometimes
deadly disease in 22 states as of April 19, the highest rate of
infection in five years.
The CDC had previously reported 555 cases in 20 states
between Jan. 1 and April 11. The current outbreak
will likely surpass the 2014 outbreak in number of cases, the
CDC said on Monday.
Iowa and Tennessee were the two states that joined the CDC
list with new measles cases.
More than half the cases recorded this year occurred in New
York City, primarily in the Williamsburg neighborhood of
The U.S. outbreak is part of a worldwide rise in the once
nearly eradicated disease. The World Health Organization
reported last week that global cases had risen nearly four-fold
in the first quarter of 2019 to 112,163 compared with the same
period last year.
A vocal fringe of parents in the United States oppose
vaccines believing, contrary to scientific evidence, that
ingredients in them can cause autism or other disorders.
(Reporting by Manojna Maddipatla in Bengaluru and Gabriella
Borter in New York; Editing by Maju Samuel and Bill Berkrot)
First Published: 2019-04-22 16:07:10
Updated 2019-04-22 16:56:01
© 2019 Thomson Reuters. All rights reserved. Reuters content is the intellectual property of Thomson Reuters or its third party content providers. Any copying, republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. "Reuters" and the Reuters Logo are trademarks of Thomson Reuters and its affiliated companies.